Sales 2024 * | 43.06M 31.32M | Sales 2025 * | 58.43M 42.5M | Capitalization | 30.3M 22.04M |
---|---|---|---|---|---|
Net income 2024 * | -7M -5.09M | Net income 2025 * | -1M -727K | EV / Sales 2024 * | 0.7 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.52 x |
P/E ratio 2024 * |
-5
x | P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.53% |
Latest transcript on Medipharm Labs Corp
Managers | Title | Age | Since |
---|---|---|---|
David Pidduck
CEO | Chief Executive Officer | - | 22-04-19 |
Greg Hunter
DFI | Director of Finance/CFO | - | 21-02-07 |
Keith Strachan
PSD | President | - | 18-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Bumby
BRD | Director/Board Member | 60 | 23-03-31 |
David Pidduck
CEO | Chief Executive Officer | - | 22-04-19 |
Shelley Martin
BRD | Director/Board Member | - | 20-06-21 |
1st Jan change | Capi. | |
---|---|---|
+40.86% | 6.16B | |
-16.30% | 4.49B | |
-9.93% | 3.17B | |
-1.58% | 3.01B | |
-1.70% | 2.57B | |
+37.23% | 1.8B | |
-12.78% | 1.62B | |
+1.02% | 1.56B | |
-12.97% | 1.53B |